GLP1R variant is associated with response to exenatide in overweight Chinese Type 2 diabetes patients
{{output}}
Aim: Exenatide is a glucagon-like peptide 1receptor agonist, having both glycemic and weight loss benefits. Given that previous pharmacogenetic studies reported inconsistent evidence of association between variants in the drug ta... ...
